NL-OMON20435招募中不适用
ong term prospective observational cohort study of the safety and efficacy of certolizumab pegol in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profile.
Reade0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients with rheumatoid arthritis in whom certolizumab pegol treatment is started;
- •2. Written informed consent.
排除标准
- •None, except for the contraindications against certolizumab pegol treatment.
研究者
相似试验
招募中
4 期
ong term prospective observational cohort study of the safety and efficacy of golimumab in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36406Jan van Breemen Instituut200
招募中
4 期
ong term prospective observational cohort study of the safety and efficacy of certolizumab pegol in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36770Jan van Breemen Instituut200
招募中
4 期
ong term prospective observational cohort study on the safety and efficacy of abatacept subcutaneus in the daily clinical practice of rheumatoid arthritisInflammatory rheumatic disease10023213NL-OMON39013Jan van Breemen Instituut100
已完成
不适用
ong term, prospective, observational cohort study evaluating the safety profile in patients with highly active relapsing multiple sclerosis (RMS) newly started on oral cladribineG35.9DRKS00015267Merck KGaA1,115
尚未招募
不适用
Prospective observational cohort study on the correlation of microbiome diversity and oncological outcome in immune checkpoint inhibitor therapyC00-C97Malignant neoplasmsDRKS00030723Rheinische Friedrich-Wilhelms-Universität Bonn100